Literature DB >> 14569430

Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy.

B Castelnuovo1, E Chiesa, S Rusconi, F Adorni, M Bongiovanni, S Melzi, P Cicconi, F Tordato, L Meroni, T Bini, A d'Arminio Monforte.   

Abstract

Presented here are the results of a cohort study conducted on 3,483 consecutive HIV/AIDS patients between January 1993 and December 2000 to determine trends in AIDS incidence and presentation. The incidence of AIDS was calculated in the general population and examined further according to gender, age (< or = or >49 years), and heterosexual behaviour as a risk factor for HIV. Multivariate analysis was used to identify variables associated with AIDS presenters (defined as patients diagnosed with AIDS within 1 month of the first HIV-positive test). The numbers of patients with AIDS classified as (i) AIDS presenters, (ii) known HIV-positive patients on antiretroviral treatment, and (iii) known HIV-positive patients not receiving antiretroviral treatment were calculated. The overall incidence of AIDS decreased over time, mainly due to the lower number of patients on antiretroviral treatment developing AIDS. Factors associated with a higher risk of being an AIDS presenter were male gender and year of HIV diagnosis. Among patients with AIDS, the proportion of AIDS presenters increased from 13.8% prior to 1997 (when protease inhibitors were introduced in Italy) to 32.5% after 1997. Variables predictive of being an AIDS presenter were male gender, age at diagnosis, and AIDS diagnosis in the years 1997-2000. Heterosexuals had a higher risk of being AIDS presenters and a lower risk of being HIV-positive and not receiving antiretroviral treatment than intravenous drug users. In Italy, AIDS occurs mainly in subjects unaware of their HIV status (especially males, the elderly, and those infected heterosexually) or in patients refusing antiretroviral therapy (mainly intravenous drug users who do not refer to specialised centres).

Entities:  

Mesh:

Year:  2003        PMID: 14569430     DOI: 10.1007/s10096-003-1038-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Authors:  B Autran; G Carcelain; T S Li; C Blanc; D Mathez; R Tubiana; C Katlama; P Debré; J Leibowitch
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

2.  Declining prevalence of HIV infection among injecting drug users entering drug treatment in Italy: 1990-1991.

Authors:  G Rezza; A De Rose; M Dorrucci; C Arpino; I Serafin
Journal:  Eur J Epidemiol       Date:  1993-11       Impact factor: 8.082

3.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

4.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

5.  Increasing proportion of late diagnosis of HIV infection among patients with AIDS in Italy following introduction of combination antiretroviral therapy.

Authors:  E Girardi; A Sampaolesi; M Gentile; G Nurra; G Ippolito
Journal:  J Acquir Immune Defic Syndr       Date:  2000-09-01       Impact factor: 3.731

6.  Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.

Authors:  S Staszewski; J Morales-Ramirez; K T Tashima; A Rachlis; D Skiest; J Stanford; R Stryker; P Johnson; D F Labriola; D Farina; D J Manion; N M Ruiz
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

7.  Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Authors:  A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

8.  Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

Authors:  W A O'Brien; P M Hartigan; D Martin; J Esinhart; A Hill; S Benoit; M Rubin; M S Simberkoff; J D Hamilton
Journal:  N Engl J Med       Date:  1996-02-15       Impact factor: 91.245

9.  HIV testing patterns: where, why, and when were persons with AIDS tested for HIV?

Authors:  P M Wortley; S Y Chu; T Diaz; J W Ward; B Doyle; A J Davidson; P J Checko; M Herr; L Conti; S A Fann
Journal:  AIDS       Date:  1995-05       Impact factor: 4.177

10.  HIV-risk behaviors of sterilized and nonsterilized women in drug-treatment programs--Philadelphia, 1989-1991.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1992-03-06       Impact factor: 17.586

View more
  4 in total

1.  Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009.

Authors:  Patricia Garcia de Olalla; Christian Manzardo; Maria A Sambeat; Inma Ocaña; Hernando Knobel; Victoria Humet; Pere Domingo; Esteve Ribera; Ana Guelar; Andres Marco; Maria J Belza; Josep M Miró; Joan A Caylà
Journal:  AIDS Res Ther       Date:  2011-07-06       Impact factor: 2.250

2.  Rate and determinants of treatment response to different antiretroviral combination strategies in subjects presenting at HIV-1 diagnosis with advanced disease.

Authors:  Antonella Esposito; Marco Floridia; Gabriella d'Ettorre; Daniele Pastori; Alessandra Fantauzzi; Paola Massetti; Giancarlo Ceccarelli; Camilla Ajassa; Vincenzo Vullo; Ivano Mezzaroma
Journal:  BMC Infect Dis       Date:  2011-12-14       Impact factor: 3.090

3.  Late Presentation of HIV Infection: Prevalence, Trends, and the Role of HIV Testing Strategies in Guangzhou, China, 2008-2013.

Authors:  Weibin Cheng; Weiming Tang; Zhigang Han; Thitikarn May Tangthanasup; Fei Zhong; Faju Qin; Huifang Xu
Journal:  Biomed Res Int       Date:  2016-09-27       Impact factor: 3.411

4.  Sociodemographic and Health Profile of Heterosexual Men Living With HIV in Ontario, Canada.

Authors:  Kristen M Wheeler; Tony Antoniou; Sandra Gardner; Lucia Light; Ramandip Grewal; Jason Globerman; Winston Husbands; Ann N Burchell
Journal:  Am J Mens Health       Date:  2017-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.